You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ampreloxetine

Showing 1 - 5 of 5
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Symptomatic Neurogenic Orthostatic Hypotension, MSA - Multiple System Atrophy Trial (Ampreloxetine, Placebo)

Not yet recruiting
  • Symptomatic Neurogenic Orthostatic Hypotension
  • MSA - Multiple System Atrophy
  • Ampreloxetine
  • Placebo
  • (no location specified)
Jan 13, 2023

Symptomatic Neurogenic Orthostatic Hypertension, nOH Trial in Miami, Orlando (Ampreloxetine)

Completed
  • Symptomatic Neurogenic Orthostatic Hypertension
  • nOH
  • Ampreloxetine
  • Miami, Florida
  • +1 more
Sep 7, 2021

Symptomatic Neurogenic Orthostatic Hypotension Trial in Worldwide (ampreloxetine)

Terminated
Has Results
  • Symptomatic Neurogenic Orthostatic Hypotension
  • ampreloxetine
  • Colorado Springs, Colorado
  • +54 more
Nov 7, 2022

Symptomatic Neurogenic Orthostatic Hypotension, MSA, Parkinson's Disease (PD) Trial in Worldwide (ampreloxetine, Placebo)

Terminated
Has Results
  • Symptomatic Neurogenic Orthostatic Hypotension
  • +3 more
  • ampreloxetine
  • Placebo
  • Sun City, Arizona
  • +81 more
Dec 29, 2022

Symptomatic Neurogenic Orthostatic Hypotension Trial in Worldwide (ampreloxetine, Placebo)

Completed
  • Symptomatic Neurogenic Orthostatic Hypotension
  • ampreloxetine
  • Placebo
  • Sun City, Arizona
  • +124 more
Sep 15, 2021